GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » EV-to-FCF

Oxygenta Pharmaceutical (BOM:524636) EV-to-FCF : (As of May. 18, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Oxygenta Pharmaceutical's Enterprise Value is ₹1,713.3 Mil. Oxygenta Pharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.0 Mil. Therefore, Oxygenta Pharmaceutical's EV-to-FCF for today is .

The historical rank and industry rank for Oxygenta Pharmaceutical's EV-to-FCF or its related term are showing as below:

BOM:524636' s EV-to-FCF Range Over the Past 10 Years
Min: -18.92   Med: 0   Max: 0
Current: -15.31

BOM:524636's EV-to-FCF is ranked worse than
100% of 520 companies
in the Drug Manufacturers industry
Industry Median: 24.215 vs BOM:524636: -15.31

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Oxygenta Pharmaceutical's stock price is ₹34.95. Oxygenta Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-6.530. Therefore, Oxygenta Pharmaceutical's PE Ratio for today is At Loss.


Oxygenta Pharmaceutical EV-to-FCF Historical Data

The historical data trend for Oxygenta Pharmaceutical's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical EV-to-FCF Chart

Oxygenta Pharmaceutical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.94 -11.00 -6.56 -13.00 -10.63

Oxygenta Pharmaceutical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -10.63 - - -

Competitive Comparison of Oxygenta Pharmaceutical's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Oxygenta Pharmaceutical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxygenta Pharmaceutical's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Oxygenta Pharmaceutical's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Oxygenta Pharmaceutical's EV-to-FCF falls into.



Oxygenta Pharmaceutical EV-to-FCF Calculation

Oxygenta Pharmaceutical's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1713.296/0
=

Oxygenta Pharmaceutical's current Enterprise Value is ₹1,713.3 Mil.
Oxygenta Pharmaceutical's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxygenta Pharmaceutical  (BOM:524636) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Oxygenta Pharmaceutical's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=34.95/-6.530
=At Loss

Oxygenta Pharmaceutical's share price for today is ₹34.95.
Oxygenta Pharmaceutical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-6.530.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Oxygenta Pharmaceutical EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxygenta Pharmaceutical (BOM:524636) Business Description

Traded in Other Exchanges
N/A
Address
Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032
Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines